This paper is only available as a PDF. To read, Please Download here.
Objectives: To characterize mupirocin-resistant methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients in a burn unit by pulsed-field gel electrophoresis and plasmid contents.
Methods: A total of 53 methicillin-resistant S. aureus, consisting of 48 mupirocin-resistant and 5 mupirocin-susceptible MRSA were compared by plasmid content and pulsed-field gel electrophoresis of Sma I digested genomic DNA.
Results: Of the 48 mupirocin-resistant isolates, 39 expressed high-level, and 9 expressed low-level mupirocin resistance. Plasmids were detected in all of the 53 isolates; however, only the high-level mupirocin-resistant isolates contained a 38 kb-conjugative plasmid that encoded high-level mupirocin resistance. Pulsed-field gel electrophoresis divided the isolates into four patterns designated types I to IV Forty-three isolates consisting of 34 high-level, 5 low-level mupirocin-resistant and 4 mupirocin-susceptible isolates defined the type-I pattern. Eight isolates, five high-level and three low-level mupirocin-resistant isolates had the type-II pulsed-field pattern. The type-III and type-IV pulsed-field patterns consisted of a single isolate each. The typed and type-II pulsed-field patterns were related and only differed by four Sma I bands.
Conclusions: Results of typing the mupirocin-resistant MRSA that closely related MRSA clones previously circulating in the unit had acquired a high-level mupirocin-resistant plasmid, and spread aided by mupirocin use.
- The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice.J Antimicrob Chemother. 1998; 41: 11-18
- Use of mupirocin ointment in the treatment of secondary infected dermatoses.J Am Acad Dermatol. 1990; 22: 886-892
- Efficacy of mupirocin in methicillin-resistant burn wound infections.Antimicrob Agents Chemother. 1989; 33: 1358-1361
- Eradication of low-level methicillin-resistant Staphylococcus aureus skin colonization with topical mupirocin.Infect Control Hosp Epidemiol. 1988; 9: 261-263
- Topical mupirocin compared with oral ampicillin in the treatment of primary and secondary skin infections.Curr Ther Res. 1987; 42: 114-120
- Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy.Br J Dermatol. 1988; 119: 189-198
- Mupirocin and eradication of Staphylococcus aureus in atopic dermatitis.Arch Dermatol. 1988; 124: 853-854
- Topical Bactroban (mupirocin) in treating burn wounds infected with methicillin-resistant staphylococci.J Burn Care Rehabil. 1990; 11: 454-459
- The use of mupirocin before skin surgery.Int J Dermatol. 1991; 30: 218-219
- Elimination of nasal carriage of Staphylococcus aureus with mupirocin (pseudomonic acid): a controlled trial.J Antimicrob Chemother. 1986; 17: 365-372
- Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak.J Antimicrob Chemother. 1988; 22: 377-384
- The value of nasal mupirocin in containing an outbreak of methicillin-resistant Staphylococcus aureus in an orthopedic unit.J Hosp Infect. 1990; 15: 137-142
- Mupirocin susceptibility in vitro and nasal eradication of epidemic methicillin-resistant Staphylococcus aureus.J Hosp Infect. 1993; 24: 237-238
- Transmissible mupirocin resistance in Staphylococcus aureus.Epidemiol Infect. 1989; 102: 261-270
- Staphylococcus aureus resistant to mupirocin.J Antimicrob Agents Chemother. 1988; 21: 141-142
- Mupirocin-resistant Staphylococcus aureus after long-term treatment of patients with epidermolysis bullosa.J Am Acad Dermatol. 1990; 22: 893-895
- Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus in western Australia.J Hosp Infect. 1994; 26: 157-165
- Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian hospitals.Infect Control Hosp Epidemiol. 1996; 17: 813-815
- Mupirocin resistance among consecutive isolates of oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus at a university hospital.Antimicrob Agents Chemother. 1994; 38: 1664-1667
- Mupirocin-resistant Staphylococcus aureus.Lancet. 1990; 335: 1095-1096
- Mupirocin-resistant Staphylococcus aureus in Auckland.N Z Med J. 1992; 105: 438
- Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term care facility with the use of mupirocin.Am J Med. 1993; 94: 371-378
- Mupirocin resistance in coagulase-negative staphylococci.J Med Microbiol. 1993; 39: 450-453
- High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl tRNA synthetase.Antimicrob Agents Chemother. 1993; 37: 32-38
- Bactroban ointment. Product Profile. SmithKline Beecham, 1992
- Conjugative transfer of highlevel mupirocin resistance from Staphylococcus haemolyticus to other staphylococci.Antimicrob Agents Chemother. 1997; 41: 693-695
- Performance standards for antimicrobial disk susceptibility tests.National Committee for Clinical Laboratory Standards, Villanova, Pennsylvania1993
- The use of cetyltrimethylammonium bromide for the rapid isolation from Staphylococcus aureus of relaxable plasmid DNA for in vitro manipulation.Letts Appl Microbiol. 1985; 1: 87-94
- Genetic analysis of methicillin-resistant Staphylococcus aureus from a Nigerian hospital.J Med Microbiol. 1993; 38: 203-208
- Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.J Clin Microbiol. 1995; 33: 2233-2239
Accepted: January 16, 1999
Received: July 22, 1998
☆Presented in part at the 8th International Congress on infectious Diseases, Boston, Massachusetts, May 15–18, 1998.
© 1999 Published by Elsevier Inc.
User licenseElsevier user license |
How you can reuse
Elsevier's open access license policy
Elsevier user license
For non-commercial purposes:
- Read, print & download
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Redistribute or republish the final article
- Sell or re-use for commercial purposes
Elsevier's open access license policy